Home › Urinary Tract Infections › NCT05711446
Double Voiding and Post-transplant UTI
A Randomized Trial of Double Voiding Versus Usual Voiding to Reduce the Incidence of Urinary Tract Infections in Kidney Transplant Recipients
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * All adult kidney transplant recipients who undergo routine follow-up at the New York Presbyterian - Weill Cornell Medicine (NYP-WCM) Transplant Clinic. Exclusion Criteria: * Kidney transplant recipients who are discharged after a transplant with an indwelling catheter (Foley)
About the study
Urinary tract infections (UTI) are common in kidney transplant recipients and are an important cause of illness and hospital admissions. Past studies have shown that about 1 out of 5 of newly transplanted patients develop UTI within their first 3 months of transplantation. Such UTIs increase the risk for blood stream infection and acute rejection of the kidney, Improvements in urinary voiding techniques may reduce the frequency of UTI. The purpose of this study is to evaluate the benefits of "double voiding" in kidney transplant recipients.
What is being tested
- Double Voiding (other)
- Regular Voiding (other)
Sponsor: Weill Medical College of Cornell University · Participants: 438 · Started: Apr 7, 2023
Contact the study team
- Muthukumar Thangamani, M.D. · Phone: 212-746-9074
- Ananda Kimm-Drapeau · Phone: 212-746-6137
Official record on ClinicalTrials.gov — NCT05711446
Locations in the U.S.
| New York | Weill Cornell Medical College / NY Presbyterian, New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.